The first drug that slows Alzheimer's has finally received FDA approval

Japanese drugmaker Eisai and US-based Biogen have received FDA approval for Leqembi, making it the first approved treatment available that can slow the progression of Alzheimer’s in patients.

Related Keywords

United States ,Japan ,Japanese ,Americans ,Christopher Viehbacher ,Alzheimer Association ,Alzheimer 39s Association ,Alzheimers Dementia ,Biogen ,Drug Targeting ,Fda ,Clinical Benefit ,Leqembi ,Drug Makers ,Plaque Buildup ,Amyloid Plaques ,